It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Long bone strength is determined by its outer shell (cortical bone), which forms by coalescence of thin trabeculae at the metaphysis (corticalization), but the factors that control this process are unknown. Here we show that SOCS3-dependent cytokine expression regulates bone corticalization. Young male and female Dmp1Cre.Socs3f/f mice, in which SOCS3 has been ablated in osteocytes, have high trabecular bone volume and poorly defined metaphyseal cortices. After puberty, male mice recover, but female corticalization is still impaired, leading to a lasting defect in bone strength. The phenotype depends on sex-steroid hormones: dihydrotestosterone treatment of gonadectomized female Dmp1Cre.Socs3f/f mice restores normal cortical morphology, whereas in males, estradiol treatment, or IL-6 deletion, recapitulates the female phenotype. This suggests that androgen action promotes metaphyseal corticalization, at least in part, via IL-6 signaling.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 St. Vincent’s Institute of Medical Research, Fitzroy, VIC, Australia; Department of Neurosurgery, Kyungpook National University Hospital, Daegu, Republic of Korea
2 St. Vincent’s Institute of Medical Research, Fitzroy, VIC, Australia; Department of Medicine at St. Vincent’s Hospital, University of Melbourne, Fitzroy, VIC, Australia
3 St. Vincent’s Institute of Medical Research, Fitzroy, VIC, Australia; Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN, USA
4 St. Vincent’s Institute of Medical Research, Fitzroy, VIC, Australia
5 Department of Medicine at St. Vincent’s Hospital, University of Melbourne, Fitzroy, VIC, Australia
6 Department of Andrology, ANZAC Research Institute, University of Sydney, Concord, NSW, Australia